GENEVA, Sept. 24 -- KYMERA THERAPEUTICS, INC. filed a patent application (IB2026/052547) for “CYCLIN-DEPENDENT KINASE 2 (CDK2) MOLECULAR GLUE DEGRADERS”. With publication no. WO/2026/196156, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 35/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....